NCT00002835: Combination Chemotherapy in Treating Patients With Lymphoma |
|
|
| Completed | 3 | 116 | US | Bleomycin Sulfate (BLM), Blenoxane, BLM, Filgrastim (G-CSF), G-CSF, Neupogen, Recombinant Interferon Alfa, Carmustine, BiCNU, BiCNUI, Cisplatin (CDDP), Platinol, Platinol-AQ, Cyclophosphamide, Cytoxan, Neosar, Cytarabine (ARA-C), ARA-C, Cytosar, DepotCyt, Cytosine arabinosine hydrochloride, Etoposide (VP-16), VePesid, Idarubicin, Idamycin, Ifosfamide, Ifex, Leucovorin Calcium, Leucovorin, Citrovorum, Wellcovorin, Melphalan, Alkeran, Methotrexate, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, mitoxantrone hydrochloride (DHAD), mitoxantrone, Novantrone, Vincristine Sulfate, Peripheral Blood Stem Cell Transplantation, autologous peripheral blood stem cells, PBSC, Radiation Therapy, RT | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Lymphoma | 02/04 | 02/04 | | |
NCT00929695: Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease |
|
|
| Completed | 3 | 164 | US | prednisone, DeCortin, Deltra, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, questionnaire administration | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia | 07/13 | 12/15 | | |
